BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
29 results:

  • 1. Tumorous formation of the forehead.
    Temelkova I; Tchernev G
    Wien Med Wochenschr; 2020 May; 170(7-8):196-198. PubMed ID: 31993874
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
    Maes A; Maes K; Vlummens P; De Raeve H; Devin J; Szablewski V; De Veirman K; Menu E; Moreaux J; Vanderkerken K; De Bruyne E
    Blood Cancer J; 2019 Nov; 9(12):87. PubMed ID: 31740676
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis.
    Liu PP; Wang KF; Jin JT; Bi XW; Sun P; Wang Y; Yang H; Li ZM; Jiang WQ; Xia Y
    Cancer Med; 2018 May; 7(5):1845-1851. PubMed ID: 29624913
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunotherapy with the trifunctional anti-cd20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent cd20-positive B cell malignancies.
    Schuster FR; Stanglmaier M; Woessmann W; Winkler B; Siepermann M; Meisel R; Schlegel PG; Hess J; Lindhofer H; Borkhardt A; Buhmann R
    Br J Haematol; 2015 Apr; 169(1):90-102. PubMed ID: 25495919
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-hodgkin's lymphoma: a retrospective single-centre study.
    Martinelli G; Montoro J; Vanazzi A; Andreola G; Liptrott S; Radice D; Negri M; Preda L; Pruneri G; Laszlo D
    Hematol Oncol; 2015 Dec; 33(4):129-35. PubMed ID: 25047267
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky hodgkin lymphoma.
    Hartridge-Lambert SK; Schöder H; Lim RC; Maragulia JC; Portlock CS
    Cancer; 2013 Mar; 119(6):1203-9. PubMed ID: 23132361
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Interstitial pneumonitis during rituximab-containing chemotherapy for non-hodgkin lymphoma.
    Liu X; Hong XN; Gu YJ; Wang BY; Luo ZG; Cao J
    Leuk Lymphoma; 2008 Sep; 49(9):1778-83. PubMed ID: 18798110
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. FcgammaRIIa polymorphism and clinical response to rituximab in non-hodgkin lymphoma patients.
    Paiva M; Marques H; Martins A; Ferreira P; Catarino R; Medeiros R
    Cancer Genet Cytogenet; 2008 May; 183(1):35-40. PubMed ID: 18474295
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases.
    Wöhrer S; Troch M; Zwerina J; Schett G; Skrabs C; Gaiger A; Jaeger U; Zielinski CC; Raderer M
    Ann Oncol; 2007 Apr; 18(4):647-51. PubMed ID: 17218490
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical hodgkin's lymphoma: a clinicopathologic study.
    Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
    J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma involving the breast. A report of four cases.
    Pisani F; Romano A; Anticoli Borza P; Marino M; Micheli A; Botti C; Petti MC
    J Exp Clin Cancer Res; 2006 Jun; 25(2):277-81. PubMed ID: 16918141
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.
    Pitman SD; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Berdeja JG; Weiss LM; Wang J
    Am J Surg Pathol; 2006 Apr; 30(4):470-6. PubMed ID: 16625093
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immunophenotypic changes and clinical outcome in B-cell lymphomas treated with rituximab.
    Seliem RM; Freeman JK; Steingart RH; Hasserjian RP
    Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):18-23. PubMed ID: 16540725
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. cFLIP expression correlates with tumour progression and patient outcome in non-hodgkin lymphomas of low grade of malignancy.
    Valente G; Manfroi F; Peracchio C; Nicotra G; Castino R; Nicosia G; Kerim S; Isidoro C
    Br J Haematol; 2006 Mar; 132(5):560-70. PubMed ID: 16445828
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides.
    Jahrsdorfer B; Mühlenhoff L; Blackwell SE; Wagner M; Poeck H; Hartmann E; Jox R; Giese T; Emmerich B; Endres S; Weiner GJ; Hartmann G
    Clin Cancer Res; 2005 Feb; 11(4):1490-9. PubMed ID: 15746051
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Monoclonal antibody therapy and laboratory medicine].
    Takeshita A
    Rinsho Byori; 2004 Nov; 52(11):917-23. PubMed ID: 15658471
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
    Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
    J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive--the Trojan Horse is being destroyed"--Part B: Malignant lymphoma.
    Cheung TW
    Cancer Invest; 2004; 22(5):787-98. PubMed ID: 15581059
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Adverse prognostic significance of cd20 positive Reed-Sternberg cells in classical hodgkin's disease.
    Portlock CS; Donnelly GB; Qin J; Straus D; Yahalom J; Zelenetz A; Noy A; O'Connor O; Horwitz S; Moskowitz C; Filippa DA
    Br J Haematol; 2004 Jun; 125(6):701-8. PubMed ID: 15180859
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-hodgkin's lymphoma.
    Friedberg JW; Kim H; Li S; Neuberg D; Boyd K; Daley H; Fisher DC; Gribben JG; Spitzer T; Freedman AS
    Bone Marrow Transplant; 2003 Oct; 32(7):681-6. PubMed ID: 13130315
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.